Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre …; Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials; Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non–small cell lung cancer; COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study; Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study; Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non–small cell lung cancer: the SELECT-1 randomized …; Amivantamab in EGFR exon 20 insertion–mutated non–small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study; Patient involvement in clinical research: why, when, and how; Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus; The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC; Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the …; Trastuzumab emtansine (T-DM1) in patients with previously treated HER2-overexpressing metastatic non–small cell lung cancer: efficacy, safety, and biomarkers; Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis; Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial; Usefulness of megestrol acetate in cancer cachexia and anorexia: a placebo-controlled study; Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non–small-cell lung cancer patients: The Spanish Lung …; Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: An alternative therapy; Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study; New molecular targeted therapies integrated with radiation therapy in lung cancer; Phase III trial comparing vinflunine with docetaxel in second-line advanced non–small-cell lung cancer previously treated with platinum-containing chemotherapy
